TNF receptor-1 is required for the formation of splenic compartments during adult, but not embryonic life

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1486-1494

  Milićević, Novica M ^a   Klaperski, Karola ^b   Nohroudi, Klaus ^b,c   Milićević, Živana ^a   Bieber, Katja ^b   Baraniec, Babett ^b   Blessenohl, Maike ^b   Kalies, Kathrin ^b   Ware, Carl F ^d   Westermann, Jürgen ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Sandford Burnham Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; TISSUE STRUCTURE; WILD TYPE;

AGING; ANIMALS; B-LYMPHOCYTE SUBSETS; CELL COMPARTMENTATION; FEMALE; FETUS; LYMPHOTOXIN BETA RECEPTOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 79251580359     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000740     Document Type: Article

References (61)

1. Junt, T., E. Scandella, and B. Ludewig. 2008. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 8: 764-775.
2. Westermann, J., B. Engelhardt, and J. C. Hoffmann. 2001. Migration of T cells in vivo: molecular mechanisms and clinical implications. Ann. Intern. Med. 135: 279-295.
3. Westermann, J., U. Bode, A. Sahle, U. Speck, N. Karin, E. B. Bell, K. Kalies, and A. Gebert. 2005. Naive, effector, and memory T lymphocytes efficiently scan dendritic cells in vivo: contact frequency in T cell zones of secondary lymphoid organs does not depend on LFA-1 expression and facilitates survival of effector T cells. J. Immunol. 174: 2517-2524.
4. Pape, K. A., D. M. Catron, A. A. Itano, and M. K. Jenkins. 2007. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26: 491-502.
5. Garside, P., E. Ingulli, R. R. Merica, J. G. Johnson, R. J. Noelle, and M. K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281: 96-99.
6. Ware, C. F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23: 787-819.
7. Scandella, E., B. Bolinger, E. Lattmann, S. Miller, S. Favre, D. R. Littman, D. Finke, S. A. Luther, T. Junt, and B. Ludewig. 2008. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9: 667-675.
8. Lo, J. C., Y. Wang, A. V. Tumanov, M. Bamji, Z. Yao, C. A. Reardon, G. S. Getz, and Y. X. Fu. 2007. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 316: 285-288.
9. Ware, C. F. 2008. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol. Rev. 223: 186-201.
10. Fütterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9: 59-70. (Pubitemid 28361295)
11. Gommerman, J. L., and J. L. Browning. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3: 642-655.
12. Summers-DeLuca, L. E., D. D. McCarthy, B. Cosovic, L. A. Ward, C. C. Lo, S. Scheu, K. Pfeffer, and J. L. Gommerman. 2007. Expression of lymphotoxinalphabeta on antigen-specific T cells is required for DC function. J. Exp. Med. 204: 1071-1081.
13. Randall, T. D., D. M. Carragher, and J. Rangel-Moreno. 2008. Development of secondary lymphoid organs. Annu. Rev. Immunol. 26: 627-650.
14. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, and P. S. Hochman. 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184: 1999-2006.
15. Tumanov, A. V., S. I. Grivennikov, A. N. Shakhov, S. A. Rybtsov, E. P. Koroleva, J. Takeda, S. A. Nedospasov, and D. V. Kuprash. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195: 106-16-106-116.
16. Pasparakis, M., S. Kousteni, J. Peschon, and G. Kollias. 2000. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell. Immunol. 201: 33-41.
17. Tkachuk, M., S. Bolliger, B. Ryffel, G. Pluschke, T. A. Banks, S. Herren, R. H. Gisler, and M. H. Kosco-Vilbois. 1998. Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J. Exp. Med. 187: 469-477.
18. Sacca, R., C. A. Cuff, W. Lesslauer, and N. H. Ruddle. 1998. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. J. Immunol. 160: 485-491.
19. Luther, S. A., A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J. G. Cyster. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169: 424-433.
20. Ludewig, B., B. Odermatt, S. Landmann, H. Hengartner, and R. M. Zinkernagel. 1998. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188: 1493-1501.
21. Aloisi, F., and R. Pujol-Borrell. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6: 205-217.
22. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
23. Cupedo, T., W. Jansen, G. Kraal, and R. E. Mebius. 2004. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 21: 655-667.
24. Westermann, J., R. Pabst, and E. Claassen. 1991. Histophysiology of autotransplanted splenic tissue. Res. Immunol. 142: 321-325.
25. Pabst, R., J. Westermann, and H. J. Rothkötter. 1991. Immunoarchitecture of regenerated splenic and lymph node transplants. Int. Rev. Cytol. 128: 215-260.
26. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94: 6319-6323.
27. Westermann, J., S. Michel, S. Lopez-Kostka, U. Bode, H. J. Rothkötter, M. Bette, E. Weihe, R. H. Straub, and R. Pabst. 1998. Regeneration of implanted splenic tissue in the rat: re-innervation is host age-dependent and necessary for tissue development. J. Neuroimmunol. 88: 67-76.
28. Milićević, N. M., K. Nohroudi, Z. Milićević, H. J. Hedrich, and J. Westermann. 2005. T cells are required for the peripheral phase of B-cell maturation. Immunology 116: 308-317. (Pubitemid 41534649)
29. Kalies, K., M. Blessenohl, J. Nietsch, and J. Westermann. 2006. T cell zones of lymphoid organs constitutively express Th1 cytokine mRNA: specific changes during the early phase of an immune response. J. Immunol. 176: 741-749. (Pubitemid 43099670)
30. Kalies, K., P. König, Y. M. Zhang, M. Deierling, J. Barthelmann, C. Stamm, and J. Westermann. 2008. Nonoverlapping expression of IL10, IL12p40, and IFNgamma mRNA in the marginal zone and T cell zone of the spleen after antigenic stimulation. J. Immunol. 180: 5457-5465.
31. De Trez, C., K. Schneider, K. Potter, N. Droin, J. Fulton, P. S. Norris, S. W. Ha, Y. X. Fu, T. Murphy, K. M. Murphy, et al. 2008. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J. Immunol. 180: 238-248.
32. Mebius, R. E., P. Rennert, and I. L. Weissman. 1997. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7: 493-504.
33. Kim, D., R. E. Mebius, J. D. MacMicking, S. Jung, T. Cupedo, Y. Castellanos, J. Rho, B. R. Wong, R. Josien, N. Kim, et al. 2000. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192: 1467-1478.
34. Gonzalez, M., F. Mackay, J. L. Browning, M. H. Kosco-Vilbois, and R. J. Noelle. 1998. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187: 997-1007.
35. Fu, Y. X., G. Huang, Y. Wang, and D. D. Chaplin. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J. Exp. Med. 187: 1009-1018.
36. Ngo, V. N., H. Korner, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189: 403-412.
37. Ansel, K. M., V. N. Ngo, P. L. Hyman, S. A. Luther, R. Förster, J. D. Sedgwick, J. L. Browning, M. Lipp, and J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309-314.
38. Leemans, R., W. Manson, J. A. Snijder, J. W. Smit, H. J. Klasen, T. H. The, and W. Timens. 1999. Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes. Ann. Surg. 229: 279-285.
39. Katakai, T., T. Hara, M. Sugai, H. Gonda, and A. Shimizu. 2003. Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand 13-producing stromal network in chronic lesions of autoimmune gastritis. J. Immunol. 171: 4359-4368. (Pubitemid 37238714)
40. White, A., D. Carragher, S. Parnell, A. Msaki, N. Perkins, P. Lane, E. Jenkinson, G. Anderson, and J. H. Caamaño. 2007. Lymphotoxin a-dependent and -independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis. Blood 110: 1950-1959.
41. Bajénoff, M., J. G. Egen, L. Y. Koo, J. P. Laugier, F. Brau, N. Glaichenhaus, and R. N. Germain. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25: 989-1001.
42. Cupedo, T., F. E. Lund, V. N. Ngo, T. D. Randall, W. Jansen, M. J. Greuter, R. de Waal-Malefyt, G. Kraal, J. G. Cyster, and R. E. Mebius. 2004. Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13. J. Immunol. 173: 4889-4896.
43. Cooney, D. R., S. E. Swanson, J. C. Dearth, M. K. Dewanjee, and R. L. Telander. 1979. Heterotopic splenic autotransplantation in prevention of overwhelming postsplenectomy infection. J. Pediatr. Surg. 14: 337-342.
44. Chiang, E. Y., G. A. Kolumam, X. Yu, M. Francesco, S. Ivelja, I. Peng, P. Gribling, J. Shu, W. P. Lee, C. J. Refino, et al. 2009. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat. Med. 15: 766-773.
45. Mebius, R. E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3: 292-303.
46. Ohata, J., N. J. Zvaifler, M. Nishio, D. L. Boyle, S. L. Kalled, D. A. Carson, and T. J. Kipps. 2005. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 174: 864-870.
47. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289.
48. Kim, M. Y., S. Rossi, D. Withers, F. McConnell, K. M. Toellner, F. Gaspal, E. Jenkinson, G. Anderson, and P. J. Lane. 2008. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 124: 166-174.
49. Peduto, L., S. Dulauroy, M. Lochner, G. F. Späth, M. A. Morales, A. Cumano, and G. Eberl. 2009. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J. Immunol. 182: 5789-5799.
50. Katakai, T., T. Hara, M. Sugai, H. Gonda, and A. Shimizu. 2004. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J. Exp. Med. 200: 783-795.
51. Westermann, J., and R. Pabst. 1986. Autotransplantation of splenic fragments: lymphocyte subsets in blood, lymph nodes and splenic tissue. Clin. Exp. Immunol. 64: 188-194.
52. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27: 2033-2042.
53. Feldmann, M., and L. Steinman. 2005. Design of effective immunotherapy for human autoimmunity. Nature 435: 612-619. (Pubitemid 40825501)
54. Haraoui, B. 2005. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis. J. Rheumatol. Suppl. 72: 46-47.
55. Scott, D. L., and G. H. Kingsley. 2006. Tumor necrosis factor inhibitors for rheumatoid arthritis. N. Engl. J. Med. 355: 704-712.
56. Kempen, J. H., E. Daniel, J. P. Dunn, C. S. Foster, S. Gangaputra, A. Hanish, K. J. Helzlsouer, D. A. Jabs, R. O. Kaçmaz, G. A. Levy-Clarke, et al. 2009. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ 339: b2480.
57. Chan, A. C., and P. J. Carter. 2010. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 10: 301-316.
58. Martin, F., and A. C. Chan. 2006. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24: 467-496.
59. Carragher, D. M., J. Rangel-Moreno, and T. D. Randall. 2008. Ectopic lymphoid tissues and local immunity. Semin. Immunol. 20: 26-42.
60. Cañete, J. D., R. Celis, C. Moll, E. Izquierdo, S. Marsal, R. Sanmartí, A. Palacín, D. Lora, J. de la Cruz, and J. L. Pablos. 2009. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann. Rheum. Dis. 68: 751-756.
61. Eberl, G. 2007. From induced to programmed lymphoid tissues: the long road to preempt pathogens. Trends Immunol. 28: 423-428. (Pubitemid 47444552)